During the past decade, Evangelische Krankenhaus Hamm conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 2 clinical trials were completed, i.e. on average, 11.8% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 2 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Evangelische Krankenhaus Hamm" #1 sponsor was "University of Ulm" with 6 trials, followed by "German CLL Study Group" with 5 trials sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 4 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored and "Goethe University" with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Evangelische Krankenhaus Hamm" #1 collaborator was "Boehringer Ingelheim" with 2 trials as a collaborator, "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator and "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Evangelische Krankenhaus Hamm" are "Acute Myeloid Leukemia" (7 trials), "Leukemia" (6 trials), "Lymphoma" (5 trials), "Acute Myeloid Leukemia (AML)" (3 trials) and "Chronic Lymphocytic Leukemia" (2 trials). Many other conditions were trialed in "Evangelische Krankenhaus Hamm" in a lesser frequency.

Most popular intervention types in "Evangelische Krankenhaus Hamm" are "Drug" (34 trials), "Biological" (13 trials), "Radiation" (5 trials), "Other" (4 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (7 trials), "vincristine sulfate" (6 trials), "doxorubicin hydrochloride" (5 trials), "filgrastim" (5 trials) and "radiation therapy" (5 trials). Other intervention names were less common.

The vast majority of trials in "Evangelische Krankenhaus Hamm" are 41 trials for "All" genders.

Currently, there are NaN active trials in "Evangelische Krankenhaus Hamm". undefined are not yet recruiting, 9 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Evangelische Krankenhaus Hamm, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Evangelische Krankenhaus Hamm, 1 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".